Skip to main content
SpringerLink
Log in

Comment to the letter to the editor “Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus” by Tamayuki Kawada, published in Acta Diabetologica as a comment to the publication “Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status”

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

The Original Article was published on 11 October 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kawada T (2023) Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus. Acta Diabetol

  2. Deischinger C, Bastian M, Leitner K, Bancher-Todesca D, Kiss H, Baumgartner-Parzer S et al (2023) Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status. Acta Diabetol. https://doi.org/10.1007/s00592-023-02151-7

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hedjazifar S, Shahidi RK, Hammarstedt A, Bonnet L, Church C, Boucher J et al (2020) The novel adipokine gremlin 1 antagonizes insulin action and is increased in type 2 diabetes and NAFLD/NASH. Diabetes 69(3):331–341

    Article  CAS  PubMed  Google Scholar 

  4. Harreiter J, Fadl H, Kautzky-Willer A, Simmons D (2020) Do women with diabetes need more intensive action for cardiovascular reduction than men with diabetes? Curr Diab Rep 20:1–11

    Article  Google Scholar 

  5. Van LJER, Tokgözoğlu LS, Badimon L, Dumanski SM, Gulati M, Hess CN et al (2023) Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. Eur Heart J 00:1–17

    Google Scholar 

Download references

Funding

The authors received no funding for the preparation of this comment to the Letter to the Editor. The initial study was funded by the Medical Scientific Fund of the Mayor of Vienna, Project Numbers 15205 and 23026. The funding source had no role in the conception of the study, study conduct or analysis and interpretation of data.

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Gender Medicine Unit, Medical University of Vienna, Waehringer Guertel 18–20, 1090, Vienna, Austria

    Carola Deischinger & Jürgen Harreiter

Authors
  1. Carola Deischinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Harreiter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jürgen Harreiter.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The initial study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Medical University of Vienna of (EK Numbers 2022/2012, 1337/2016, acquired in 2012 and 2016). No additional ethical approval was obtained for the preparation of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deischinger, C., Harreiter, J. Comment to the letter to the editor “Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus” by Tamayuki Kawada, published in Acta Diabetologica as a comment to the publication “Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status”. Acta Diabetol 61, 137–138 (2024). https://doi.org/10.1007/s00592-023-02200-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-023-02200-1

Search

Navigation